
Clinical Decision Analytics
Retinal imaging and AI platform that supports faster and more effective diagnosis and management of patients with Age-Related Macular Degeneration
Age-Related Macular Degeneration is the leading cause of vision loss for people 50 years of age and older.
The global health impact and cost of undiagnosed and untreated AMD is severe,
and it's only getting worse.
300 MILLION
Estimated number of people who will experience moderate to severe vision loss because of AMD by 2040.
Annual Direct Healthcare Costs
$100 Billion US
$343 Billion globally
We believe the devastating health impacts of AMD can be significantly reduced, and even prevented, with a better approach to early-stage detection and risk monitoring
Optina's AI-Driven Clinical Decision Support
Preserving Vision

We combine our FDA 510(k) cleared hyperspectral camera with leading AI capabilities to enable eye specialists to more accurately diagnose and manage early, intermediate and late-stage retinal disease, including monitoring therapeutic effectiveness in at-risk patients.
Key Capabilities
